Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr 28;334(7599):901.
doi: 10.1136/bmj.39160.702188.AD.

Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA

Cathie Sudlow  1
Affiliations
Review

Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA

Cathie Sudlow. BMJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: I was involved in the cited report on clopidogrel and dipyridamole and in planning a trial (of aspirin alone or with these agents) that did not proceed as a potential sponsor wished to modify it. I am on the Antithrombotic Trialists' Collaboration's steering committee and received £500 from Sanofi in 1998 to speak on the Trialists' results at a general practitioners' educational meeting. I'm also a member of the No Free Lunch movement.

Figures

None
Meta-analysis of randomised trials of aspirin plus dipyridamole versus aspirin alone in patients with a prior ischaemic stroke or transient ischaemic attack (outcome: stroke, myocardial infarction, or vascular death) (adapted from the ESPRIT Study Group5)
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

References

    1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. - PMC - PubMed
    1. Lip GYH, Rothwell P, Sudlow C. Stroke prevention. Clinical evidence. www.clinicalevidence.org/ceweb/conditions/cvd/0207/0207.jspwww.clinicalevidence.org/ceweb/conditions/cvd/0207/0207.jsp - PubMed
    1. Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, et al. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technol Assess 2004;8(38):1-196. - PubMed
    1. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European secondary prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13. - PubMed
    1. ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006;367:1665-73. - PubMed

MeSH terms